top of page

News & Insights

Rubix LS Partners with Kiffik Biomedical to Revolutionize Early Cancer Detection Through Innovative Interstitial Fluid and Aptamer Technologies

Rubix LS Partners with Kiffik Biomedical to Revolutionize Early Cancer Detection Through Innovative Interstitial Fluid and Aptamer Technologies

Rubix LS joins the Equity 2030 Alliance

Rubix LS joins the Equity 2030 Alliance

Rubix LS and TheraSyn Bio Announce Joint Venture for Project Panacea, a Novel Topical Breast Cancer Therapy

Rubix LS and TheraSyn Bio Announce Joint Venture for Project Panacea, a Novel Topical Breast Cancer Therapy

Rubix LS Selected as Member of ARPA-H Investor Catalyst Hub Spoke Network

Rubix LS Selected as Member of ARPA-H Investor Catalyst Hub Spoke Network

Rubix LS Reveals Groundbreaking Access to Over 12 Million Diverse Patient Data Sets

Rubix LS Reveals Groundbreaking Access to Over 12 Million Diverse Patient Data Sets

Rubix LS: Honored with the 2023 Biotech Startup Award for Promoting Diversity, Equity, and Inclusion

Rubix LS: Honored with the 2023 Biotech Startup Award for Promoting Diversity, Equity, and Inclusion

Rubix LS Joins CancerX As A Founding Member

Rubix LS Joins CancerX As A Founding Member

Pioneering Partnership to Revolutionize Clinical Trials: 360Medlink and Rubix LS Join Forces

Pioneering Partnership to Revolutionize Clinical Trials: 360Medlink and Rubix LS Join Forces

Advancing Diversity In Clinical Development

Advancing Diversity In Clinical Development

Clinical Trial ‘Next Generation’ Workforce Fuels Diversity Optimism

Clinical Trial ‘Next Generation’ Workforce Fuels Diversity Optimism

bottom of page